An experimental cancer therapy extracts a patient’s immune cells, re-engineers them to learn how to target their cancer, and then feeds them back into the body. It may soon be commercially available for treatment of leukemia and lymphoma.

See the source article by following the link below:
An experimental cancer therapy extracts a patient’s immune cells, re-engineers them to learn how to target their cancer, and then feeds them back into the body. It may soon be commercially available for treatment of leukemia and lymphoma.